Immune Checkpoint Inhibitor-associated Myocarditis: Clinical Trials

1 trial for Immune Checkpoint Inhibitor-associated Myocarditis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. .

Follow Immune Checkpoint Inhibitor-associated Myocarditis: new trials by email Literature Review of Immune Checkpoint Inhibitor-associated Myocarditis trials Research Report on Immune Checkpoint Inhibitor-associated Myocarditis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ATROPOS: Survival Analysis of ICI-associated Myocarditis
Immune Checkpoint Inhibitor-associated Myocarditis
RecruitingGroupe Hospitalier Pitie-Salpetriere15002026-05-202026-06-10

Narrower conditions

Myocarditis (1)  ·  Myotoxicity (1)

Broader conditions

Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Radiation Injuries (1)  ·  Wounds and Injuries (1)

Sponsors

Groupe Hospitalier Pitie-Salpetriere (1)

Countries

France (1)